Ian Gary Reddin

Publications

8 publications

Page 1 of 1

Residual cancer cells after apparent complete pathological response to neoadjuvant therapy in oesophageal adenocarcinoma

Robert C. Walker, Jack Harrington, Stella P. Breininger, Oliver Pickering, Samuel L. Hill, Benjamin P. Sharpe, Ben Grace, Ian Reddin, Rushda Rajak, Antigoni Manousopoulou, Spiros D. Garbis, Zoë S. Walters, Matthew J.J. Rose-Zerilli & Timothy J. Underwood, 2024, The British journal of surgery, 111(4)

DOI: 10.1093/bjs/znae103

Type: article

Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma

Nicola Smith, Ian Reddin, Paige Policelli, Sunwoo Oh, Rémi Buisson, Nur Zainal, Emma Howes, Benjamin Jenkins, Ian Tracy, Benjamin Sharpe, Damian Amendra, Christopher Hanley, Emma King, Gareth Thomas, Mark Edmond, Simak Ali, Ke Zheng, Nagayasu Egawa, John Doorbar, Michael Carpenter, Reuben Harris, Anjali Rao, Sangeetha Mahadevan & Tim Fenton, 2024

DOI: 10.21203/rs.3.rs-3997426/v1

Type: other

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

Eleanor O'Brien, Carmen Tse, Ian Tracy, Ian Reddin, Joanna Selfe, Jane Gibson, William Tapper, Reuben J. Pengelly, Jinhui Gao, Ewa Aladowicz, Gemma Petts, Khin Thway, Sergey Popov, Anna Kelsey, Timothy J. Underwood, Janet Shipley & Zoë S. Walters, 2023, Clinical Epigenetics, 15(1)

DOI: 10.1186/s13148-023-01583-w

Type: article

Large inherent variability in data derived from highly standardised cell culture experiments

Ian G. Reddin, Tim R. Fenton, Mark N. Wass & Martin Michaelis, 2023, Pharmacological Research, 188(2), 106671

DOI: 10.1016/j.phrs.2023.106671

Type: article

Value of p53 sequencing in the prognostication of head and neck cancer

Shadi Basyuni, Gareth Nugent, Ashley Ferro, Eleanor Barker, Ian Reddin, Oliver Jones, Matt Lechner, Ben O'Leary, Terry Jones, Liam Masterson, Tim Fenton & Andrew Schache, 2022, Scientific Reports, 12(1), 20776

DOI: 10.1038/s41598-022-25291-2

Type: article

Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance

Ankur Chakravarthy, Ian Reddin, Stephen Henderson, Cindy Dong, Nerissa Kirkwood, Maxmilan Jeyakumar, Daniela Rothschild Rodriguez, Natalia Gonzalez Martinez, Jacqueline McDermott, Xiaoping Su, Nagayasau Egawa, Christina S. Fjeldbo, Vilde Eide Skingen, Heidi Lyng, Mari Kyllesø Halle, Camilla Krakstad, Afschin Soleiman, Susanne Sprung, Matt Lechner, Peter J.I. Ellis, Mark Wass, Martin Michaelis, Heidi Fiegl, Helga Salvesen, Gareth J Thomas, John Doorbar, Kerry Chester, Andrew Feber & Tim R. Fenton, 2022, Nature Communications, 13(1)

DOI: 10.1038/s41467-022-33544-x

Type: article

YM155-adapted cancer cell lines reveal drug- induced heterogeneity and enable the identification of biomarker candidates for the acquired resistance setting

Martin Michaelis, Mark N. Wass, Ian Reddin, Yvonne Voges, Florian Rothweiler, Stephanie Hehlgans, Jaroslav Cinatl, Marco Mernberger, Andrea Nist, Thorsten Stiewe, Franz Rödel & Jindrich Cinatl, 2020, Cancers, 12(5)

DOI: 10.3390/cancers12051080

Type: article

Changes associated with Ebola virus adaptation to novel species

Morena Pappalardo, Ian G. Reddin, DIego Cantoni, Jeremy S. Rossman, Martin Michaelis & Mark N. Wass, 2017, Bioinformatics, 33(13), 1911-1915

DOI: 10.1093/bioinformatics/btx065

Type: article

Dr Ian Reddin

Connect with Ian

Publications